What is the recommended follow-up/surveillance schedule following organ preservation treatment approach for cT1-2N0 rectal cancer?
Taking into account follow up from NEO, OPERA and other organ preservation trials?
Community PollStarted
What does your typical imaging surveillance include following organ preservation treatment approach for stage I rectal cancer?
183 physicians have voted
Join Mednetto vote and see how they answered.
2 Answers
Mednet MemberInvited Expert
Medical Oncology · OHSU Knight-Legacy Health Cancer Collaborative
Answered on
Patients with stage I rectal cancer treated with organ preservation require close surveillance to rule out tumor regrowth and local recurrence that may be salvaged with radical surgery. The highest risk of recurrence is within 2 years after completion of neoadjuvant therapy and patients should be fo...
Join for free or sign in to see the full answer
Mednet MemberInvited Expert
Radiation Oncology · University of Mississippi Medical Center
Answered on
Here's what we know.
- Recurrences are often asymptomatic hence, it is unreliable to follow up based on symptoms alone. Besides, by the time recurrence become symptomatic, they are often locally advanced and not amenable for salvage.
- MRI (or EUS) is better than CT in evaluating rectal tumors especial...
Join for free or sign in to see the full answer